These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27997036)

  • 1. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
    Marquié M; Normandin MD; Meltzer AC; Siao Tick Chong M; Andrea NV; Antón-Fernández A; Klunk WE; Mathis CA; Ikonomovic MD; Debnath M; Bien EA; Vanderburg CR; Costantino I; Makaretz S; DeVos SL; Oakley DH; Gomperts SN; Growdon JH; Domoto-Reilly K; Lucente D; Dickerson BC; Frosch MP; Hyman BT; Johnson KA; Gómez-Isla T
    Ann Neurol; 2017 Jan; 81(1):117-128. PubMed ID: 27997036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
    Marquié M; Normandin MD; Vanderburg CR; Costantino IM; Bien EA; Rycyna LG; Klunk WE; Mathis CA; Ikonomovic MD; Debnath ML; Vasdev N; Dickerson BC; Gomperts SN; Growdon JH; Johnson KA; Frosch MP; Hyman BT; Gómez-Isla T
    Ann Neurol; 2015 Nov; 78(5):787-800. PubMed ID: 26344059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Marquié M; Agüero C; Amaral AC; Villarejo-Galende A; Ramanan P; Chong MST; Sáez-Calveras N; Bennett RE; Verwer EE; Kim SJW; Dhaynaut M; Alvarez VE; Johnson KA; McKee AC; Frosch MP; Gómez-Isla T
    Acta Neuropathol Commun; 2019 Oct; 7(1):164. PubMed ID: 31661038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.
    Marquié M; Verwer EE; Meltzer AC; Kim SJW; Agüero C; Gonzalez J; Makaretz SJ; Siao Tick Chong M; Ramanan P; Amaral AC; Normandin MD; Vanderburg CR; Gomperts SN; Johnson KA; Frosch MP; Gómez-Isla T
    Acta Neuropathol Commun; 2017 Oct; 5(1):75. PubMed ID: 29047416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
    Ono M; Sahara N; Kumata K; Ji B; Ni R; Koga S; Dickson DW; Trojanowski JQ; Lee VM; Yoshida M; Hozumi I; Yoshiyama Y; van Swieten JC; Nordberg A; Suhara T; Zhang MR; Higuchi M
    Brain; 2017 Mar; 140(3):764-780. PubMed ID: 28087578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
    Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
    Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.
    Coakeley S; Cho SS; Koshimori Y; Rusjan P; Harris M; Ghadery C; Kim J; Lang AE; Wilson A; Houle S; Strafella AP
    J Cereb Blood Flow Metab; 2017 Sep; 37(9):3150-3160. PubMed ID: 28155586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue.
    Aguero C; Dhaynaut M; Normandin MD; Amaral AC; Guehl NJ; Neelamegam R; Marquie M; Johnson KA; El Fakhri G; Frosch MP; Gomez-Isla T
    Acta Neuropathol Commun; 2019 Mar; 7(1):37. PubMed ID: 30857558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
    Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
    Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
    Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases.
    Vermeiren C; Motte P; Viot D; Mairet-Coello G; Courade JP; Citron M; Mercier J; Hannestad J; Gillard M
    Mov Disord; 2018 Feb; 33(2):273-281. PubMed ID: 29278274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Lagarde J; Olivieri P; Caillé F; Gervais P; Baron JC; Bottlaender M; Sarazin M
    J Neurol; 2019 Dec; 266(12):3087-3097. PubMed ID: 31535269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Whitwell JL; Lowe VJ; Tosakulwong N; Weigand SD; Senjem ML; Schwarz CG; Spychalla AJ; Petersen RC; Jack CR; Josephs KA
    Mov Disord; 2017 Jan; 32(1):124-133. PubMed ID: 27787958
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Tsai RM; Bejanin A; Lesman-Segev O; LaJoie R; Visani A; Bourakova V; O'Neil JP; Janabi M; Baker S; Lee SE; Perry DC; Bajorek L; Karydas A; Spina S; Grinberg LT; Seeley WW; Ramos EM; Coppola G; Gorno-Tempini ML; Miller BL; Rosen HJ; Jagust W; Boxer AL; Rabinovici GD
    Alzheimers Res Ther; 2019 Jan; 11(1):13. PubMed ID: 30704514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Holland N; Malpetti M; Rittman T; Mak EE; Passamonti L; Kaalund SS; Hezemans FH; Jones PS; Savulich G; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2022 Mar; 145(1):340-348. PubMed ID: 34398211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcortical
    Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontotemporal dementia with the V337M
    Spina S; Schonhaut DR; Boeve BF; Seeley WW; Ossenkoppele R; O'Neil JP; Lazaris A; Rosen HJ; Boxer AL; Perry DC; Miller BL; Dickson DW; Parisi JE; Jagust WJ; Murray ME; Rabinovici GD
    Neurology; 2017 Feb; 88(8):758-766. PubMed ID: 28130473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased basal ganglia binding of
    Smith R; Schain M; Nilsson C; Strandberg O; Olsson T; Hägerström D; Jögi J; Borroni E; Schöll M; Honer M; Hansson O
    Mov Disord; 2017 Jan; 32(1):108-114. PubMed ID: 27709757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.